Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Completed1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT06853470Not ApplicableCompleted
Prospective Evaluation for Receiving SynFlow 3.0 Interventional Circulatory Support in High-risk PCI: A Randomized Controlled Trial
Coronary Arterial Disease (CAD)High Risk PCI
StudychairStart date: 2024-09-10

Research Network

Collaboration Network

19 collaborators·65 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Shanghai Zhongshan Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jianan Wang, Phd

Second Affiliated Hospital, Zhejiang University, School of Medicine

Related
1 trials

Shared therapeutic areas:

Coronary Arterial Disease (CAD)High Risk PCI

Worked with same sponsors:

ForQaly Medical (Shanghai) Co., Ltd
Collaborated on 1 trial
Similarity Score24%

Zuyi Yuan, Phd

First Affiliated Hospital Xi'an Jiaotong University

Related
1 trials

Shared therapeutic areas:

Coronary Arterial Disease (CAD)High Risk PCI

Worked with same sponsors:

ForQaly Medical (Shanghai) Co., Ltd
Collaborated on 1 trial
Similarity Score24%

Yan Li, Phd

The Second Affiliated Hospital of Air Force Military Medical University

Related
1 trials

Shared therapeutic areas:

Coronary Arterial Disease (CAD)High Risk PCI

Worked with same sponsors:

ForQaly Medical (Shanghai) Co., Ltd
Collaborated on 1 trial
Similarity Score24%

Jiancheng Xiu, Phd

Nanfang Hospital, Southern Medical University

Related
1 trials

Shared therapeutic areas:

Coronary Arterial Disease (CAD)High Risk PCI

Worked with same sponsors:

ForQaly Medical (Shanghai) Co., Ltd
Collaborated on 1 trial
Similarity Score24%

Chuanyu Gao, Phd

Fuwai Huazhong Cardiovascular Hospital

Related
1 trials

Shared therapeutic areas:

Coronary Arterial Disease (CAD)High Risk PCI

Worked with same sponsors:

ForQaly Medical (Shanghai) Co., Ltd
Collaborated on 1 trial
Similarity Score24%

Yining Yang, Phd

People's Hospital of Xinjiang Uygur Autonomous Region

Related
1 trials

Shared therapeutic areas:

Coronary Arterial Disease (CAD)High Risk PCI

Worked with same sponsors:

ForQaly Medical (Shanghai) Co., Ltd
Collaborated on 1 trial
Similarity Score24%

Ming Bai, Phd

LanZhou University

Related
1 trials

Shared therapeutic areas:

Coronary Arterial Disease (CAD)High Risk PCI

Worked with same sponsors:

ForQaly Medical (Shanghai) Co., Ltd
Collaborated on 1 trial
Similarity Score24%

Cheng Zhang, Phd

Qilu Hospital of Shandong University

Related
1 trials

Shared therapeutic areas:

Coronary Arterial Disease (CAD)High Risk PCI

Worked with same sponsors:

ForQaly Medical (Shanghai) Co., Ltd
Collaborated on 1 trial
Similarity Score24%

Lin Zhao, Phd

Beijing Chao Yang Hospital

Related
1 trials

Shared therapeutic areas:

Coronary Arterial Disease (CAD)High Risk PCI

Worked with same sponsors:

ForQaly Medical (Shanghai) Co., Ltd
Collaborated on 1 trial
Similarity Score24%

Yan Wang

Xiamen Cardiovascular Hospital

Related
1 trials

Shared therapeutic areas:

Coronary Arterial Disease (CAD)High Risk PCI

Worked with same sponsors:

ForQaly Medical (Shanghai) Co., Ltd
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06853470Not ApplicableStudyChair

Prospective Evaluation for Receiving SynFlow 3.0 Interventional Circulatory Support in High-risk PCI: A Randomized Controlled Trial

Coronary Arterial Disease (CAD)High Risk PCI
Completed

All 1 trials loaded